Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Heterodimeric antibodies to CD3 X CD20

Heterodimeric antibodies to CD3 X CD20

US Patent 9850320 · Granted Dec 26, 2017

Estimated economic value: $10,388,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

LAG-3 targeted heterodimeric fusion proteins containing IL-15/IL-15RA Fc-fusion 2025
LAG-3 targeted heterodimeric fusion proteins containing IL-15/IL-15RA Fc-fusion 2025
LAG-3 targeted heterodimeric fusion proteins containing IL-15/IL-15RA Fc-fusion 2025
Methods and compositions for inhibiting CD32B expressing cells in IGG4-related d2025
Methods and compositions for inhibiting CD32B expressing cells in IGG4-related d2025
Methods and compositions for inhibiting CD32B expressing cells in IGG4-related d2025
Anti-human C5 antibodies2025
Method of manufacturing diester-based compound2025
CTLA4-Ig immunoadhesins2025
Heterodimeric human IgG1 polypeptides with isoelectric point modifications2025
Targeted heterodimeric Fc fusion proteins containing NKG2D antigen binding domai2025
Targeted heterodimeric Fc fusion proteins containing NKG2D antigen binding domai2025